MORGAN STANLEY - 31 Dec 2024 SCHEDULE 13G/A Report for Arbutus Biopharma Corp Common Shares (ABUS)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Arbutus Biopharma Corp Common Shares
Symbol
ABUS
Shares outstanding
189M shares
Disclosed Ownership
21.5M shares
Ownership
11.4%
Form type
SCHEDULE 13G/A
Filing time
03 Feb 2025, 15:26:45 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 11.4% 21.5M 0 21.5M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Investment Management Inc. 11.2% 21.2M 0 21.2M Deidre A Downes Authorized Signatory, Morgan Stanley Investment Management Inc.